The DNA and RNA Banking Services Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Transportation Service, Processing Service, Storage Service, Quality Control Service, Data Storage, Others), By Specimen Type (Blood, Buccal Swabs & Hair Follicles, Others), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others), By End-user (Academic Research, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Others).
The DNA and RNA banking services market in 2024 serves the demand for biobanking and repository services that collect, process, store, and distribute DNA and RNA samples for biomedical research, precision medicine initiatives, and diagnostic applications in healthcare. DNA and RNA banking facilities maintain repositories of human biological specimens, including blood, tissue, saliva, and cell samples, along with associated clinical and genetic data, to support genetic research, biomarker discovery, and personalized medicine approaches. Market dynamics are driven by factors such as the increasing adoption of genomic medicine and molecular diagnostics, the growing demand for large-scale biorepositories and population cohorts, and advancements in sample storage and retrieval technologies for long-term specimen preservation and utilization. Collaboration between biobanking organizations, research institutions, and healthcare systems drives innovation and market growth in DNA and RNA banking services, supporting accelerated biomedical research and translational medicine efforts for improved healthcare outcomes.
A significant trend in the DNA and RNA Banking Services market is the growing demand for personalized medicine. With advancements in genomics and molecular biology, there is increasing recognition of the role of genetic information in understanding disease susceptibility, treatment response, and prognosis. DNA and RNA banking services enable individuals to preserve their genetic material for future use in diagnostic testing, pharmacogenomics, and personalized treatment approaches. This trend is driven by the shift towards precision medicine, which aims to tailor medical interventions to individual genetic profiles, lifestyle factors, and environmental influences. As healthcare providers and patients seek more targeted and effective treatment options, the demand for DNA and RNA banking services is expected to rise, reshaping the landscape of genetic testing and driving market expansion in the DNA and RNA Banking Services segment.
A key driver in the DNA and RNA Banking Services market is the rising interest in genetic testing and research across healthcare, pharmaceutical, and academic sectors. Genetic testing has become increasingly accessible and affordable, allowing individuals to gain insights into their genetic predispositions for various diseases and conditions. Additionally, advancements in high-throughput sequencing technologies and bioinformatics have enabled large-scale genomic studies and personalized medicine initiatives. DNA and RNA banking services play a crucial role in supporting genetic research by providing repositories of genetic material for population-based studies, disease-specific biobanks, and clinical trials. As the importance of genetic information in healthcare decision-making and drug development continues to grow, the demand for DNA and RNA banking services is expected to increase, driving market growth in the DNA and RNA Banking Services segment.
An opportunity for growth in the DNA and RNA Banking Services market lies in the expansion into direct-to-consumer (DTC) genetic testing services. DTC genetic testing allows individuals to access genetic testing services directly from commercial companies without the involvement of healthcare providers or genetic counselors. While DTC genetic testing has raised concerns about privacy, accuracy, and interpretation of results, it has also democratized access to genetic information and empowered consumers to take proactive steps towards managing their health. DNA and RNA banking services can complement DTC genetic testing by offering storage solutions for genetic material collected through saliva or blood samples. Additionally, by partnering with DTC genetic testing companies or offering bundled services, DNA and RNA banking providers can capitalize on the growing consumer interest in genetic testing and personalized health management. Embracing expansion into DTC genetic testing presents a compelling opportunity for market differentiation and revenue growth in the DNA and RNA Banking Services segment, offering solutions that empower individuals to make informed decisions about their health and wellness based on their genetic makeup.
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
23andMe Inc
Brooks Life Sciences
deCODE genetics
DNA Genotek Inc
EasyDNA
GoodCell
Infinity Biologix
LGC Biosearch Technologies
PreventionGenetics
ProteoGenex
Thermo Fisher Scientific Inc
US Biolab Corp Inc
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the DNA and RNA Banking Services Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the DNA and RNA Banking Services Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 DNA and RNA Banking Services Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global DNA and RNA Banking Services Market Size Outlook, $ Million, 2021 to 2030
3.2 DNA and RNA Banking Services Market Outlook By Type, $ Million, 2021 to 2030
3.3 DNA and RNA Banking Services Market Outlook By Product, $ Million, 2021 to 2030
3.4 DNA and RNA Banking Services Market Outlook By Application, $ Million, 2021 to 2030
3.5 DNA and RNA Banking Services Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of DNA and RNA Banking Services Market Industry
4.2 Key Market Trends in DNA and RNA Banking Services Market Industry
4.3 Potential Opportunities in DNA and RNA Banking Services Market Industry
4.4 Key Challenges in DNA and RNA Banking Services Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global DNA and RNA Banking Services Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global DNA and RNA Banking Services Market Outlook By Segments
7.1 DNA and RNA Banking Services Market Outlook by Segments
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
8 North America DNA and RNA Banking Services Market Analysis And Outlook To 2030
8.1 Introduction to North America DNA and RNA Banking Services Markets in 2024
8.2 North America DNA and RNA Banking Services Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America DNA and RNA Banking Services Market size Outlook by Segments, 2021-2030
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
9 Europe DNA and RNA Banking Services Market Analysis And Outlook To 2030
9.1 Introduction to Europe DNA and RNA Banking Services Markets in 2024
9.2 Europe DNA and RNA Banking Services Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe DNA and RNA Banking Services Market Size Outlook By Segments, 2021-2030
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
10 Asia Pacific DNA and RNA Banking Services Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific DNA and RNA Banking Services Markets in 2024
10.2 Asia Pacific DNA and RNA Banking Services Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific DNA and RNA Banking Services Market size Outlook by Segments, 2021-2030
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
11 South America DNA and RNA Banking Services Market Analysis And Outlook To 2030
11.1 Introduction to South America DNA and RNA Banking Services Markets in 2024
11.2 South America DNA and RNA Banking Services Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America DNA and RNA Banking Services Market size Outlook by Segments, 2021-2030
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
12 Middle East And Africa DNA and RNA Banking Services Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa DNA and RNA Banking Services Markets in 2024
12.2 Middle East and Africa DNA and RNA Banking Services Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa DNA and RNA Banking Services Market size Outlook by Segments, 2021-2030
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
23andMe Inc
Brooks Life Sciences
deCODE genetics
DNA Genotek Inc
EasyDNA
GoodCell
Infinity Biologix
LGC Biosearch Technologies
PreventionGenetics
ProteoGenex
Thermo Fisher Scientific Inc
US Biolab Corp Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others
By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others
By Application
Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Others
By End-user
Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global DNA and RNA Banking Services Market is one of the lucrative growth markets, poised to register a 5.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
23andMe Inc, Brooks Life Sciences, deCODE genetics, DNA Genotek Inc, EasyDNA, GoodCell, Infinity Biologix, LGC Biosearch Technologies, PreventionGenetics, ProteoGenex, Thermo Fisher Scientific Inc, US Biolab Corp Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume